184 related articles for article (PubMed ID: 22761933)
1. Mutagenesis-mediated decrease of pathogenicity as a feature of the mutant spectrum of a viral population.
Sanz-Ramos M; Rodríguez-Calvo T; Sevilla N
PLoS One; 2012; 7(6):e39941. PubMed ID: 22761933
[TBL] [Abstract][Full Text] [Related]
2. Ribavirin-resistant variants of foot-and-mouth disease virus: the effect of restricted quasispecies diversity on viral virulence.
Zeng J; Wang H; Xie X; Li C; Zhou G; Yang D; Yu L
J Virol; 2014 Apr; 88(8):4008-20. PubMed ID: 24453363
[TBL] [Abstract][Full Text] [Related]
3. Tolerance to mutations in the foot-and-mouth disease virus integrin-binding RGD region is different in cultured cells and in vivo and depends on the capsid sequence context.
Gutiérrez-Rivas M; Pulido MR; Baranowski E; Sobrino F; Sáiz M
J Gen Virol; 2008 Oct; 89(Pt 10):2531-2539. PubMed ID: 18796722
[TBL] [Abstract][Full Text] [Related]
4. Foot-and-mouth disease virus mutant with decreased sensitivity to ribavirin: implications for error catastrophe.
Sierra M; Airaksinen A; González-López C; Agudo R; Arias A; Domingo E
J Virol; 2007 Feb; 81(4):2012-24. PubMed ID: 17151116
[TBL] [Abstract][Full Text] [Related]
5. Lethal mutagenesis of foot-and-mouth disease virus involves shifts in sequence space.
Perales C; Henry M; Domingo E; Wain-Hobson S; Vartanian JP
J Virol; 2011 Dec; 85(23):12227-40. PubMed ID: 21917974
[TBL] [Abstract][Full Text] [Related]
6. Coevolution of cells and viruses in a persistent infection of foot-and-mouth disease virus in cell culture.
de la Torre JC; Martínez-Salas E; Diez J; Villaverde A; Gebauer F; Rocha E; Dávila M; Domingo E
J Virol; 1988 Jun; 62(6):2050-8. PubMed ID: 2835509
[TBL] [Abstract][Full Text] [Related]
7. Counteracting quasispecies adaptability: extinction of a ribavirin-resistant virus mutant by an alternative mutagenic treatment.
Perales C; Agudo R; Domingo E
PLoS One; 2009; 4(5):e5554. PubMed ID: 19436746
[TBL] [Abstract][Full Text] [Related]
8. Attenuation of Foot-and-Mouth Disease Virus by Engineered Viral Polymerase Fidelity.
Rai DK; Diaz-San Segundo F; Campagnola G; Keith A; Schafer EA; Kloc A; de Los Santos T; Peersen O; Rieder E
J Virol; 2017 Aug; 91(15):. PubMed ID: 28515297
[TBL] [Abstract][Full Text] [Related]
9. An antiviral mechanism investigated with ribavirin as an RNA virus mutagen for foot-and-mouth disease virus.
Gu CJ; Zheng CY; Zhang Q; Shi LL; Li Y; Qu SF
J Biochem Mol Biol; 2006 Jan; 39(1):9-15. PubMed ID: 16466632
[TBL] [Abstract][Full Text] [Related]
10. Curing of foot-and-mouth disease virus from persistently infected cells by ribavirin involves enhanced mutagenesis.
Airaksinen A; Pariente N; Menéndez-Arias L; Domingo E
Virology; 2003 Jul; 311(2):339-49. PubMed ID: 12842623
[TBL] [Abstract][Full Text] [Related]
11. Molecular dissection of a viral quasispecies under mutagenic treatment: positive correlation between fitness loss and mutational load.
Arias A; Isabel de Ávila A; Sanz-Ramos M; Agudo R; Escarmís C; Domingo E
J Gen Virol; 2013 Apr; 94(Pt 4):817-830. PubMed ID: 23239576
[TBL] [Abstract][Full Text] [Related]
12. Topology of evolving, mutagenized viral populations: quasispecies expansion, compression, and operation of negative selection.
Ojosnegros S; Agudo R; Sierra M; Briones C; Sierra S; González-López C; Domingo E; Cristina J
BMC Evol Biol; 2008 Jul; 8():207. PubMed ID: 18637173
[TBL] [Abstract][Full Text] [Related]
13. Foot-and-mouth disease virus low-fidelity polymerase mutants are attenuated.
Xie X; Wang H; Zeng J; Li C; Zhou G; Yang D; Yu L
Arch Virol; 2014 Oct; 159(10):2641-50. PubMed ID: 24888311
[TBL] [Abstract][Full Text] [Related]
14. Foot-and-mouth disease virus type O specific mutations determine RNA-dependent RNA polymerase fidelity and virus attenuation.
Li C; Wang H; Yuan T; Woodman A; Yang D; Zhou G; Cameron CE; Yu L
Virology; 2018 May; 518():87-94. PubMed ID: 29455065
[TBL] [Abstract][Full Text] [Related]
15. Potential benefits of sequential inhibitor-mutagen treatments of RNA virus infections.
Perales C; Agudo R; Tejero H; Manrubia SC; Domingo E
PLoS Pathog; 2009 Nov; 5(11):e1000658. PubMed ID: 19911056
[TBL] [Abstract][Full Text] [Related]
16. New vaccine design based on defective genomes that combines features of attenuated and inactivated vaccines.
Rodríguez-Calvo T; Ojosnegros S; Sanz-Ramos M; García-Arriaza J; Escarmís C; Domingo E; Sevilla N
PLoS One; 2010 Apr; 5(4):e10414. PubMed ID: 20454676
[TBL] [Abstract][Full Text] [Related]
17. Contribution of a Multifunctional Polymerase Region of Foot-and-Mouth Disease Virus to Lethal Mutagenesis.
de la Higuera I; Ferrer-Orta C; Moreno E; de Ávila AI; Soria ME; Singh K; Caridi F; Sobrino F; Sarafianos SG; Perales C; Verdaguer N; Domingo E
J Virol; 2018 Oct; 92(20):. PubMed ID: 30068642
[TBL] [Abstract][Full Text] [Related]
18. In vivo analysis of the stability and fitness of variants recovered from foot-and-mouth disease virus quasispecies.
Carrillo C; Borca M; Moore DM; Morgan DO; Sobrino F
J Gen Virol; 1998 Jul; 79 ( Pt 7)():1699-706. PubMed ID: 9680133
[TBL] [Abstract][Full Text] [Related]
19. Pathogenesis of virulent and attenuated foot-and-mouth disease virus in cattle.
Arzt J; Pacheco JM; Stenfeldt C; Rodriguez LL
Virol J; 2017 May; 14(1):89. PubMed ID: 28464897
[TBL] [Abstract][Full Text] [Related]
20. Polymerase Fidelity Contributes to Foot-and-Mouth Disease Virus Pathogenicity and Transmissibility
Li C; Shi J; Wang H; Rivera-Serrano EE; Yang D; Zhou G; Sun C; Cameron CE; Yu L
J Virol; 2020 Dec; 95(1):. PubMed ID: 33028719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
